SARS-CoV-2 spike/Nb2 complex with 1 RBD up (local refinement at 5.6 A)

Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.

SARS-CoV-2 spike/Nb2 complex with 1 RBD up

Severe acute respiratory syndrome coronavirus 2

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

SARS-CoV-2, VIRAL PROTEIN-IMMUNE SYSTEM complex, Nanobody